[go: up one dir, main page]

TR199801739T2 - Viral enfeksiyonlar�n tedavisinde flukonazol kullan�m�. - Google Patents

Viral enfeksiyonlar�n tedavisinde flukonazol kullan�m�.

Info

Publication number
TR199801739T2
TR199801739T2 TR1998/01739T TR9801739T TR199801739T2 TR 199801739 T2 TR199801739 T2 TR 199801739T2 TR 1998/01739 T TR1998/01739 T TR 1998/01739T TR 9801739 T TR9801739 T TR 9801739T TR 199801739 T2 TR199801739 T2 TR 199801739T2
Authority
TR
Turkey
Prior art keywords
treatment
fluconazole
viral infections
composition
cancers
Prior art date
Application number
TR1998/01739T
Other languages
English (en)
Turkish (tr)
Inventor
Berger Camden James
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/674,180 external-priority patent/US5908855A/en
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR199801739T2 publication Critical patent/TR199801739T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR1998/01739T 1995-08-04 1996-07-30 Viral enfeksiyonlar�n tedavisinde flukonazol kullan�m�. TR199801739T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US188995P 1995-08-04 1995-08-04
US08/674,180 US5908855A (en) 1996-07-16 1996-07-16 Compositions for treating viral infections

Publications (1)

Publication Number Publication Date
TR199801739T2 true TR199801739T2 (xx) 1998-12-21

Family

ID=26669622

Family Applications (2)

Application Number Title Priority Date Filing Date
TR1998/00270T TR199800270T1 (xx) 1995-08-04 1996-07-30 Kanser hastal�klar�n�n ilerlemesini �nlemede flukonazol kullan�m�.
TR1998/01739T TR199801739T2 (xx) 1995-08-04 1996-07-30 Viral enfeksiyonlar�n tedavisinde flukonazol kullan�m�.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR1998/00270T TR199800270T1 (xx) 1995-08-04 1996-07-30 Kanser hastal�klar�n�n ilerlemesini �nlemede flukonazol kullan�m�.

Country Status (18)

Country Link
EP (1) EP0841921A2 (xx)
JP (1) JPH11510187A (xx)
KR (1) KR19990036138A (xx)
CN (1) CN1195288A (xx)
AR (1) AR003175A1 (xx)
AU (1) AU711966B2 (xx)
BR (1) BR9609966A (xx)
CA (1) CA2229024A1 (xx)
CZ (1) CZ33798A3 (xx)
HU (1) HUP9903420A3 (xx)
IL (1) IL123095A0 (xx)
MX (1) MX9800998A (xx)
NO (1) NO980473L (xx)
NZ (2) NZ503921A (xx)
PL (1) PL324904A1 (xx)
SK (1) SK14198A3 (xx)
TR (2) TR199800270T1 (xx)
WO (1) WO1997005873A2 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
FR2742405B1 (fr) * 1995-12-13 1998-02-27 Cgea Comp Gen Entre Auto Unite motrice susceptible d'etre accouplee a une enceinte roulante et vehicule resultant
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
BR9915164A (pt) * 1998-11-09 2003-01-07 Idec Pharma Corp Tratamento de malignidades hematológicas associadas com células de tumor circulantes usando anticorpo anti-cd20 quimérico
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US7004915B2 (en) * 2001-08-24 2006-02-28 Kci Licensing, Inc. Negative pressure assisted tissue treatment system
EP1895012A1 (en) * 2006-08-30 2008-03-05 Universitätsklinikum Freiburg Method for inducing tumor apoptosis by increasing nitric oxide levels
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2019185521A1 (en) * 2018-03-26 2019-10-03 Westfälische Wilhelms-Universität Münster Ergosterol-biosynthesis inhibitor and influenza virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
HUP9903420A2 (hu) 2000-03-28
WO1997005873A2 (en) 1997-02-20
AR003175A1 (es) 1998-07-08
EP0841921A2 (en) 1998-05-20
NO980473D0 (no) 1998-02-03
AU711966B2 (en) 1999-10-28
CA2229024A1 (en) 1997-02-20
AU6683396A (en) 1997-03-05
WO1997005873A3 (en) 1997-03-27
IL123095A0 (en) 1998-09-24
SK14198A3 (en) 1999-03-12
KR19990036138A (ko) 1999-05-25
PL324904A1 (en) 1998-06-22
CZ33798A3 (cs) 1998-06-17
NO980473L (no) 1998-04-03
HUP9903420A3 (en) 2001-12-28
JPH11510187A (ja) 1999-09-07
MX9800998A (es) 1998-04-30
NZ503921A (en) 2002-03-01
BR9609966A (pt) 1999-02-02
TR199800270T1 (xx) 1998-05-21
CN1195288A (zh) 1998-10-07
NZ315184A (en) 2000-05-26

Similar Documents

Publication Publication Date Title
TR199801739T2 (xx) Viral enfeksiyonlar�n tedavisinde flukonazol kullan�m�.
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
TR199802423T2 (xx) Konsantre antikor terkibi.
ES2110386T3 (es) Conjugados de interferon.
SE9704546D0 (sv) Novel compounds
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
DK0971717T3 (da) Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
TR200100054T2 (tr) Paroksetin metansülfonat
ATE231872T1 (de) Thiazolopyrimidinderivate
TR199701535T1 (xx) Bis-1,2,4- triazolleri, kanserlerin tedavisi i�in bir ila� �retilmesinde kullan�m�.
IT1285770B1 (it) Composti corticoidei
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
TR199800244T2 (xx) Griseofulvinin, kanserlerin ilerlemesini �nlemede kullan�m�.
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
TR199900161T2 (xx) T�bbi �r�nler �retimi i�in aminler.
AU9534398A (en) Novel pharmaceutical composition
PT841912E (pt) 2-aminocarbonil-1,2-bis(metilsulfonil)-1-(substituido)-hidrazinas antitumor
TR200003794T2 (tr) Kaplama amilleri ve bunların kullanımı.
TR199802504T2 (xx) N�rotoksik yaralanmalar�n tedavisi i�in bukminsterflirin kullan�lmas�.
TR200103219T2 (tr) Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
ATE217619T1 (de) Endothelin-rezeptor-antagonisten